NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 668814 | 1-Oxa-4,7,10,13,16-pentaazacyclononadecane, cyclic peptide derivative | 0.0141370771633662 | -0.10139868 |
NSC 673450 | Null | 0.0141370771633662 | 0.14477872 |
NSC 677624 | Null | 0.0141370771633662 | 0.12873004 |
NSC 716344 | Null | 0.0141370771633662 | 0.21383746 |
NSC 735318 | Null | 0.0141370771633662 | 0.098180453 |
NSC 741942 | Null | 0.0141370771633662 | 0.28660195 |
NSC 756304 | GW678313X | 0.0141370771633662 | -0.28752917 |
NSC 757949 | (1R,2E,6R,10E,11aS,13S,14aR)-6-(2-(benzyloxy)ethyl)-1,13-dihydroxy-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one | 0.0141370771633662 | -0.079178412 |
NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.0144962130699212 | 0.27883997 |
NSC 287459 | Cytarabine AY | 0.0144962130699212 | 0.40852853 |